Bill Title: As enacted, permits the direct administration of buprenorphine mono or buprenorphine without the use of naloxone as a treatment for substance use disorder under certain circumstances. - Amends TCA Title 53, Chapter 10; Title 53, Chapter 11 and Title 63.
Sponsorship: Moderate Partisan Bill (Republican 6-1)
Status: (Passed) 2018-04-17 - Pub. Ch. 674
[HB2002 Detail]
Note: Tennessee does not provide sufficient information to determine typical named revision of bills. Therefore only drafts are captured, the highest order draft will always be the current version.
Bill Drafts
| Revision | Date | Format | Source | View |
|---|
| Chaptered | 2018-04-13 | PDF | Link | View |
| Draft (#1) | 2018-01-29 | PDF | Link | View (#1) |
Amendments
| Amendment | Date | Disposition | Format | Source | View |
|---|
| HA0730 | Not Avail | Proposed | PDF | Link | View |
Supplemental Documents
